Learn More
BACKGROUND Because of the emergence of chloroquine resistance in Mali, artemether-lumefantrine (AL) or artesunate-amodiaquine (AS+AQ) are recommended as first-line therapy for uncomplicated malaria, but have not been available in Mali until recently because of high costs. METHODS From July 2005 to January 2006, a randomized open-label trial of three oral(More)
  • 1